PPARA and Insulin resistance: In line with this, we newly synthesized and screened six 2-methyl-2-(o-tolyloxy)propanoic acid derivatives as candidates for PPAR pan agonists and examined their effects on insulin resistance and dyslipidemia in genetically obese db/db mice.